Biotechnology Innovation Organization (BIO)
1225 Eye Street, NW
Suite 400
Washington
D.C.
20005-5958
United States
Tel: 202-962-9200
Fax: 202-962-9201
Website: http://www.bio.org/
Email: info@bio.org
About Biotechnology Innovation Organization (BIO)
The Biotechnology Innovation Organization (BIO) is the largest trade organization to serve and represent the emerging biotechnology industry in the United States and around the globe. The organization's leadership and service-oriented guidance have helped advance the industry and bring the benefits of biotechnology to the people of the world.
As the leading voice for the biotechnology industry, BIO represents companies of all sizes engaged in the development of products and services in the areas of agriculture, biomedicine, diagnostics, food, energy and environmental applications. Though biotechnology's future is bright, the industry's success will depend on the commitment, energy and direction of the group that helps guide its growth. BIO is a vital forum and an invaluable focal point to bring together the resources and expertise to meet critical challenges and serve the needs of its members.
3305 articles with Biotechnology Innovation Organization (BIO)
-
BioSpace Movers & Shakers, Oct. 11
10/11/2019
Companies strengthen their leadership teams and boards of directors with these appointments. -
During his 14-year tenure as head of BIO, Greenwood oversaw a significant growth at the organization, more than tripling its size to 176 employees with an 85 million operating budget.
-
According to the U.S. Centers for Disease Control and Prevention, about 2 million people each year are infected with antibiotic-resistant bacteria and 23,000 people die as a result. A recent study by the UK government estimated that by 2050, as many as 10 million people could die worldwide from a...
-
BIO Asia-Taiwan 2019 Showcased Biotech as the Region’s Next Growth Engine
7/29/2019
Event Brought Together Biopharma Executives and Investors from Around the World for Deal Making and Partnering Opportunities
-
BIO Applauds Enactment of the Pandemic and All-Hazards Preparedness and Advancing Innovation Act
6/25/2019
Legislation will strengthen pipeline of medical countermeasures against serious public health threats
-
EWIB Partners with BIO to Promote Gender Diversity on Corporate Boards
6/25/2019
The new partnership will help change the landscape of life science boardrooms by expanding executive women’s resources and visibility
-
A first for Taiwan, BIO Asia-Taiwan 2019 to be held in Taipei, 24 July, with BIO’s president Jim Greenwood to attend
6/12/2019
As a sign of its international importance, the BIO Asia-Taiwan 2019 exhibition will feature 18 national pavilions, while the conference will feature speakers from 25 countries
-
BioSpace Movers and Shakers, June 7
6/7/2019
Pharma and biotech companies strengthen their executive and leadership teams with new appointments. -
Final Day of BIO International Convention Begins in Philadelphia
6/6/2019
Thursday programming will emphasize personalized medicine for oncology, rare disease clinical trials and biotech venture capitalism
-
BIO International Convention Begins Day Three with Jamie Dimon Keynote Address
6/5/2019
Wednesday programming will feature timely discussions on diversity, inclusion and R&D investment
-
New Jersey Governor Phil Murphy to be Presented 2019 BIO Governor of the Year Award
6/4/2019
Governor Murphy will receive the award in conjunction with the 2019 BIO International Convention.
-
BIO Elects Dr. Jeremy Levin as New Board Chair
6/4/2019
A new slate of officers and Board members were elected during the 2019 BIO International Convention
-
Cofactor Joins FNIH Biomarkers Consortium to Add Predictive Immune Modeling Expertise as New Resource for Multidimensional Biomarker Discovery
6/4/2019
Contributing to both the Cancer and Inflammation and Immunity Steering Committees
-
Can-Fite Participating in One-on-One Partnering Meetings at the BIO International Convention on June 3-6, 2019
6/4/2019
Can-Fite BioPharma Ltd. announced that the Company’s VP of Business Development, Sari Fishman, is conducting one-on-one meetings with pharmaceutical companies for potential distribution and partnerships for the Company’s drug candidates, Piclidenoson and Namodenoson, at the BIO International Convention 2019 on June 3-6, 2019 in Philadelphia.
-
BIO Releases Bioscience Economic Development Guide - June 4, 2019
6/4/2019
The Biotechnology Innovation Organization released “Transforming Ideas into Advances: Best Practices in State and Regional Bioscience Economic Development Initiatives” at the 2019 BIO International Convention.
-
BIO International Convention Begins Day Two with Keynote from Pulitzer Prize-Winning Author Siddhartha Mukherjee
6/4/2019
Author, physician and oncologist will discuss the history and progress of moving the science of genetics and cancer from the lab to the real world
-
BIO International Convention Kicks Off in Philadelphia to Celebrate and Inspire the Future of Biotech
6/3/2019
The world’s premier life sciences event returns to Philadelphia for four days of inspiring keynote speeches, fireside chats and educational programming
-
Elite High School Scientists Headed to BIO 2019 to Face Off in the BioGENEius Challenge
5/30/2019
The Biotechnology Institute announced the 15 student winners who will advance to the final stages of the 2019 BioGENEius Challenge this coming week at the BIO International Convention in Philadelphia, Pennsylvania.
-
Influential CEO Jamie Dimon to Deliver Keynote at BIO 2019
4/30/2019
JPMorgan Chase & Co. Chairman and CEO will talk leadership, risk-taking and healthcare
-
The Biotechnology Innovation Organization (BIO) announced on April 16 that it was implementing a program to improve gender, racial, ethnic and LGBTQ diversity on the boards of directors, executive suites and functional leadership positions in the biopharma industry.